PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER
Clinical trials for PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First-in-China trial tests 'Living Drug' for Tough-to-Treat prostate cancer
Disease control Recruiting nowThis is an early-stage study testing a new type of cell therapy for men with advanced prostate cancer that has spread and no longer responds to standard hormone treatments. Researchers will give patients immune cells (NK cells) that have been specially engineered in a lab to targ…
Matched conditions: PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER
Phase: EARLY_PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New immune cell attack tested for tough prostate cancer
Disease control Recruiting nowThis early-stage study is testing a new type of immunotherapy for men with advanced prostate cancer that has stopped responding to standard hormone treatments. Doctors are using specially engineered immune cells, called CAR-NK cells, designed to find and kill prostate cancer cell…
Matched conditions: PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER
Phase: EARLY_PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New weapon tested in fight against tough cancers
Disease control Recruiting nowThis early-stage study is testing a new type of cancer drug called MBRC-201 in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe and effective dose and to see how the body processes the drug. The study will en…
Matched conditions: PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: MBrace Therapeutics • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC